TREATMENT OF BRIAN METASTASES WITH INHIBITORS OF ENDOTHELIN RECEPTORS IN COMBINATION WITH A CYTOTOXIC CHEMOTHERAPY AGENT
- 专利权人:
- BOARD OF REGENTS;THE UNIVERSITY OF TEXAS SYSTEM
- 发明人:
- FIDLER ISAIAH J,KIM SUN-JIN
- 申请号：
- ZA201200980
- 公开号：
- ZA201200980B
- 申请日:
- 2012.02.09
- 申请国别(地区):
- ZA
- 年份:
- 2012
- 代理人:
- 摘要：
- The disclosure relates to an endothelin receptor antagonist for use in the prevention or treatment of brain metastases in combination with a cytotoxic chemotherapy agent, radiotherapy or both. The endothelin receptor antagonist may for example be bosentan, macitentan or a mixture of bosentan and macitentan.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- Leczenie przerzutów do mózgu z zastosowaniem inhibitorów receptorów endoteliny w skojarzeniu z cytotoksycznym środkiem chemioterapeutycznym
- TREATMENT OF ASTROCYTES-TUMOR CELLS INHIBITORS OF ENDOTHELIN RECEPTORS
- TREATMENT OF ASTROCYTES-TUMOR CELLS INHIBITORS OF ENDOTHELIN RECEPTORS
- Zdravljenje možganskih metastaz z inhibitorji endotelinskih receptorjev v kombinaciji s citotoksičnim kemoterapevtskim sredstvom
- A confrontation of transplantable endocrine receptors in the prevention or treatment of metastasism in the brain, combined with cytochemistry, radiotherapy, or both； used to inhibit the protection of metabolic brain cells from cell death by celestial bodies. R is induced by cytotoxic chemotherapies and used to treat metabolic brain tumors.
